EUVIMEDEUVIMED entdecken
Open Access

T-Cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains/Cluster of Differentiation 40 Cellular Nanovesicles Carrying Oxaliplatin Exhibited Superior Pancreatic Cancer Cells Therapy

Wenlong Chen, Zining Zhang, Chuangchuang Zhao, Bo Wang, Xiang Liao, Qinghua Li, Dongqing Wang, Shengxiang Fu iD, Hsiang-I Tsai iD

ACS Pharmacology & Translational Science · 10.04.2026 · 9 (4) · 1010-1020

DOI: 10.1021/acsptsci.6c00065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 28.03.2026. Verfasst von Wenlong Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Imaging and Artificial Intelligence, Jiangsu University, Zhenjiang 212001, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Jiangsu Provincial Department of Education, Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

TIGIT/CD155 axisbiomimetic drug deliverychemo-immunotherapyimmune evasionmagnetic resonance imaging (MRI)pancreatic ductal adenocarcinoma (PDAC)

Autor:innen und Institutionen

  • Institute of Medical Imaging and Artificial Intelligence, Jiangsu University, Zhenjiang 212001, China.

ORCID-Profile: Shengxiang Fu, Hsiang-I Tsai

Förderung

  • Jiangsu Provincial Department of Education
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • Science and Technology Bureau of Zhenjiang
  • Jinshan talents in the medical field of Zhenjiang
  • Basic Research Program of Zhenjiang City
  • Jiangsu Health Commission

Zitieren

APA

Chen, W., Zhang, Z., Zhao, C., Wang, B., Liao, X., Li, Q., Wang, D., Fu, S., & Tsai, H. I. (2026). T-Cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains/Cluster of Differentiation 40 Cellular Nanovesicles Carrying Oxaliplatin Exhibited Superior Pancreatic Cancer Cells Therapy. ACS Pharmacology & Translational Science, 9(4), 1010-1020. https://doi.org/10.1021/acsptsci.6c00065

Vancouver

Chen W, Zhang Z, Zhao C, Wang B, Liao X, Li Q, et al. T-Cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains/Cluster of Differentiation 40 Cellular Nanovesicles Carrying Oxaliplatin Exhibited Superior Pancreatic Cancer Cells Therapy. ACS Pharmacology & Translational Science. 2026;9(4):1010-1020. doi:10.1021/acsptsci.6c00065

BibTeX
@article{Chen2026,
  author = {Chen, Wenlong and Zhang, Zining and Zhao, Chuangchuang and Wang, Bo and Liao, Xiang and Li, Qinghua and Wang, Dongqing and Fu, Shengxiang and Tsai, Hsiang-I},
  title = {T-Cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains/Cluster of Differentiation 40 Cellular Nanovesicles Carrying Oxaliplatin Exhibited Superior Pancreatic Cancer Cells Therapy},
  journal = {ACS Pharmacology & Translational Science},
  year = {2026},
  volume = {9},
  number = {4},
  pages = {1010--1020},
  doi = {10.1021/acsptsci.6c00065}
}
Kostenlos starten →